Results 241 to 250 of about 59,314 (277)
Some of the next articles are maybe not open access.
Pentacycle derivatives as cannabinoid CB1 receptor ligands
Bioorganic & Medicinal Chemistry Letters, 2009Cannabinoid CB-1 receptors have been the focus of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and obesity-related metabolic disorders were reported in 2001. To further evaluate the properties of CB receptors, we have designed and efficiently prepared a series of pentacycle derivatives.
Suk Ho, Lee +9 more
openaire +2 more sources
Substituted pyrimidines as cannabinoid CB1 receptor ligands
Bioorganic & Medicinal Chemistry Letters, 2009Cannabinoid CB1 receptors have been the avenue of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and obesity-related metabolic disorders were reported in 2001. To further evaluate the properties of CB receptors, we have designed and efficiently prepared a series of substituted pyrimidines based ...
Min Ju, Kim +8 more
openaire +2 more sources
CB1 cannabinoid receptor induction in experimental stroke
Annals of Neurology, 2000Cannabinoids protect cortical neurons from ischemic injury by interacting with CB1 receptors. Because a variety of neuroprotective genes are induced in cerebral ischemia, we examined the effect of experimental stroke, produced by 20 minutes of middle cerebral artery occlusion in rats, on CB1 receptor expression.
K L, Jin +3 more
openaire +2 more sources
Molecular Pharmacology, 1995
The recently cloned CB2 cannabinoid receptor subtype was stably transfected into AtT-20 and Chinese hamster ovary cells to compare the binding and signal transduction properties of this receptor with those of the CB1 receptor subtype.
C. Felder +8 more
semanticscholar +1 more source
The recently cloned CB2 cannabinoid receptor subtype was stably transfected into AtT-20 and Chinese hamster ovary cells to compare the binding and signal transduction properties of this receptor with those of the CB1 receptor subtype.
C. Felder +8 more
semanticscholar +1 more source
Tetrazole-biarylpyrazole derivatives as cannabinoid CB1 receptor antagonists
Bioorganic & Medicinal Chemistry Letters, 2008Cannabinoid CB1 receptors have been the focus of extensive studies since the first clinical results of rimonabant (SR141716) for the treatment of obesity and related metabolic disorders were reported in 2001. To further evaluate the properties of CB receptors, we have designed a new series of tetrazole-biarylpyrazoles.
Suk Youn, Kang +6 more
openaire +2 more sources
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor
Nature Chemical Biology, 2019Zhenhua Shao +8 more
semanticscholar +1 more source
Astroglial type-1 cannabinoid receptor (CB1): A new player in the tripartite synapse.
Neuroscience, 2016J. F. O. D. Cruz +6 more
semanticscholar +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.
Neuroscience, 1998K. Tsou +4 more
semanticscholar +1 more source

